105 related articles for article (PubMed ID: 24784399)
1. Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies.
Silva-Rodríguez J; Aguiar P; Sánchez M; Mosquera J; Luna-Vega V; Cortés J; Garrido M; Pombar M; Ruibal A
Med Phys; 2014 May; 41(5):052502. PubMed ID: 24784399
[TBL] [Abstract][Full Text] [Related]
2. Comment on "Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies" [Med. Phys. 41, 052502 (2014)].
Buj S; Tendero K; Marthan R; Laffon E
Med Phys; 2014 Dec; 41(12):127101. PubMed ID: 25471986
[No Abstract] [Full Text] [Related]
3. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
4. Defining a radiotherapy target with positron emission tomography.
Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.
Tylski P; Stute S; Grotus N; Doyeux K; Hapdey S; Gardin I; Vanderlinden B; Buvat I
J Nucl Med; 2010 Feb; 51(2):268-76. PubMed ID: 20080896
[TBL] [Abstract][Full Text] [Related]
6. Simulated FDG-PET studies for the assessment of SUV quantification methods.
Silva-Rodríguez J; Aguiar P; Domínguez-Prado I; Fierro P; Ruibal Á
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):13-8. PubMed ID: 25107595
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Analysis of Torso FDG-PET Scans by Using Anatomical Standardization of Normal Cases from Thorough Physical Examinations.
Hara T; Kobayashi T; Ito S; Zhou X; Katafuchi T; Fujita H
PLoS One; 2015; 10(5):e0125713. PubMed ID: 26020960
[TBL] [Abstract][Full Text] [Related]
8. The determination of patient dose from (18)F-FDG PET/CT examination.
Khamwan K; Krisanachinda A; Pasawang P
Radiat Prot Dosimetry; 2010 Sep; 141(1):50-5. PubMed ID: 20400773
[TBL] [Abstract][Full Text] [Related]
9. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
[TBL] [Abstract][Full Text] [Related]
10. SUV correction for injection errors in FDG-PET examination.
Miyashita K; Takahashi N; Oka T; Asakawa S; Lee J; Shizukuishi K; Inoue T
Ann Nucl Med; 2007 Dec; 21(10):607-13. PubMed ID: 18092139
[TBL] [Abstract][Full Text] [Related]
11. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo simulation of PET images for injection dose optimization.
Boldyš J; Dvořák J; Skopalová M; Bělohlávek O
Int J Numer Method Biomed Eng; 2013 Sep; 29(9):988-99. PubMed ID: 23281273
[TBL] [Abstract][Full Text] [Related]
16. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA
Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
[TBL] [Abstract][Full Text] [Related]
17. Topical Sensor for the Assessment of Injection Quality for 18F-FDG, 68Ga-PSMA and 68Ga-DOTATATE Positron Emission Tomography.
Sanchez S; Currie GM
J Med Imaging Radiat Sci; 2020 Jun; 51(2):247-255. PubMed ID: 32089515
[TBL] [Abstract][Full Text] [Related]
18. Impact and correction of the bladder uptake on 18 F-FCH PET quantification: a simulation study using the XCAT2 phantom.
Silva-Rodríguez J; Tsoumpas C; Domínguez-Prado I; Pardo-Montero J; Ruibal Á; Aguiar P
Phys Med Biol; 2016 Jan; 61(2):758-73. PubMed ID: 26732644
[TBL] [Abstract][Full Text] [Related]
19. Monte-Carlo simulations of clinically realistic respiratory gated (18)F-FDG PET: application to lesion detectability and volume measurements.
Vauclin S; Michel C; Buvat I; Doyeux K; Edet-Sanson A; Vera P; Gardin I; Hapdey S
Comput Methods Programs Biomed; 2015 Jan; 118(1):84-93. PubMed ID: 25459525
[TBL] [Abstract][Full Text] [Related]
20. Findings of 2-fluoro-2-deoxy-d-glucose positron emission tomography in hemorrhoids.
Tsai SC; Jeng LB; Yeh JJ; Lin CC; Chen JH; Lin WY; Kao CH
Abdom Imaging; 2011 Oct; 36(5):548-51. PubMed ID: 21153025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
